Amino acids residues are commonly submitted to various physicochemical modifications occurring at physiological pH and temperature. Post-translational modifications (PTMs) require comprehensive characterization because of their major influence on protein structure and involvement in numerous in vivo process or signaling. Mass spectrometry (MS) has gradually become an analytical tool of choice to characterize PTMs; however, some modifications are still challenging because of sample faint modification levels or difficulty to separate an intact peptide from modified counterparts before their transfer to the ionization source. Here, we report the implementation of capillary zone electrophoresis coupled to electrospray ionization tandem mass spectrometry (CZE-ESI-MS/MS) by the intermediate of a sheathless interfacing for independent and highly sensitive characterization of asparagine deamidation (deaN) and aspartic acid isomerization (isoD). CZE selectivity regarding deaN and isoD was studied extensively using different sets of synthetic peptides based on actual tryptic peptides. Results demonstrated CZE ability to separate the unmodified peptide from modified homologous exhibiting deaN, isoD or both independently with a resolution systematically superior to 1.29. Developed CZE-ESI-MS/MS method was applied for the characterization of monoclonal antibodies and complex protein mixture. Conserved CZE selectivity could be demonstrated even for complex samples, and foremost results obtained showed that CZE selectivity is similar regardless of the composition of the peptide. Separation of modified peptides prior to the MS analysis allowed to characterize and estimate modification levels of the sample independently for deaN and isoD even for peptides affected by both modifications and, as a consequence, enables to distinguish the formation of L-aspartic acid or D-aspartic acid generated from deaN. Separation based on peptide modification allowed, as supported by the ESI efficiency provided by CZE-ESI-MS/MS properties, and enabled to characterize and estimate studied PTMs with an unprecedented sensitivity and proved the relevance of implementing an electrophoretic driven separation for MS-based peptide analysis.
Introduction
Amino acids side chains of proteins and peptides may undergo various chemical reactions occurring at physiological temperature and pH. Those modifications, commonly referred as post-translational modifications (PTMs), include deamidation, oxidation, phosphorylation, N-terminal acetylation, glutamic acid (Glu) cyclization, isomerization, glycosylation or disulfide bonds exchange for instance. [1] PTMs have a determining impact on biochemical activity of proteins. Indeed, they are involved in inhibition or activation of proteins mainly by modifying their tertiary and quaternary structure likewise acting as biochemical signals transmitter or molecular clocks. [2, 3] One of the most common PTM, occurring on asparagine (Asn) and glutamine (Gln) residues, is deamidation, which additionally might lead to isomerization when forming aspartic acid. Deamidation corresponds to the hydrolysis of the side chain amide bond to a free carboxylic group (Fig. 1 ). [4] Modification kinetic is increased at elevated temperature and pH (≥8) or when the susceptible amino acid is followed by a small, flexible residue such as glycine, whose low steric hindrance leaves the amide bond exposed for reaction. [5] In isomerization/racemization, the α-carbon of aspartic acid can have two different configurations inducing two configuration isomers: D-aspartic acid (Asp) and Lisoaspartic acid (isoAsp). [4] Alongside with Asp isomerization resulting from Asn deamidation to both Asp isomers, Asp residues may also spontaneously experience isomerization by the formation of an instable succinimide intermediate. Because of their significant role in biochemical pathways, deamidation and isomerization have been subject to intensive research activities in order to improve their qualitative and quantitative characterization. [6, 7] Mass spectrometry (MS) has gradually taken a major role in PTM characterization because of its outstanding selectivity and sensitivity, especially tandem mass spectrometry (MS/MS), which enables in numerous cases to identify modified amino acid residues by attributing mass shifts of fragment ions. [8] MS often requires combination with a separation technique like nanoflow liquid chromatography (nanoLC) or capillary electrophoresis (CE) in order to limit competition during the electrospray ionization (ESI) process and maximize signal sensitivity. Ion suppression and ionization competition are common phenomena in ESI that may hamper PTM detection: protein modification is usually faint while a major part of the sample remains intact. Without separation prior to the MS analysis, ionization of a weakly abundant modified peptide might be suppressed during ionization, leading to the inability to detect the considered PTM. Currently, Asn deamidation and Asp isomerization occurring on protein are characterized by MS using a bottom-up proteomic workflow where the sample of interest is undergoing proteolytic digestion. [9] The peptide mixture is separated and characterized using reverse phase nanoLC-MS/MS instrumental settings. However, using this analytical strategy, the modification must involve a significant change in hydrophobicity in order to enable the separation of a modified peptide from the intact homologous. Recently, our group developed a method using sheathless capillary zone electrophoresis (CZE) hyphenated to high-resolution MS/MS to perform in a single analysis the simultaneous characterization of different aspects of a protein defining its primary structure. [10] We also demonstrated successfully application of this methodology to perform the biosimilarity assessment of different approved therapeutic monoclonal antibodies (mAbs) compared with their respective biosimilar candidate. [11] Recently, CE hyphenated to ESI MS (CE-ESI-MS) is meeting renewed interest. [12] [13] [14] Conventional sheath-liquid CE-ESI-MS interfacing tends to suffer from reduced sensitivity, therefore opposing to one of the major characteristics of MS. On the contrary, innovative CE-ESI-MS coupling strategies provide an optimal sensitivity especially because of operating flow rates (<50 nl/min), enabling the production of a nanoESI. [15, 16] In the present work, we demonstrate the interest of using CZE, in complement with the ESI-MS analysis, for the separation of peptide mixtures in order to detect and characterize Asn deamidation as well as Asp isomerization. A comprehensive study was carried out using different sets of synthetic peptides, based on actual proteolytic peptides, showing successful separation and independent characterization of intact peptides from homologous exhibiting Asn deamidation, Asp isomerization and even for peptides containing both modifications in the same experiment. CZE selectivity was further studied for the primary structure characterization of the therapeutic mAb trastuzumab. Trastuzumab tryptic digest was analyzed by sheathless CZE-ESI-MS/MS. MS data were used to characterize several Asn deamidation and Asp isomerization sites of interests. The characteristics provided by the CZE separation are particularly interesting for mAbs characterization because these modifications can influence the potency of therapeutic proteins and therefore are categorized as critical quality attributes for biotherapeutics. [17, 18] Finally, a moderately complex protein mixture was characterized in a similar manner to investigate the conservation of CZE selectivity for complex samples composed of several dozens of proteins. Universal Proteomic Standard 1 (UPS1) was selected as complex peptide mixture to evaluate the analytical method. Sample was spiked with several peptides in order to demonstrate strictly the conserved selectivity of the separation even for complex peptide mixture. Experiments performed proved additionally the excellent compatibility of CZE intrinsic characteristics with the ESI-MS such as background electrolyte composition or operating flow rate below 50 nl/min, bringing CZE-ESI-MS/MS as a valuable alternative for biological sample characterization particularly for experiments focusing on PTMs characterization.
Materials and methods

Materials
Chemicals were of analytical grade or high purity grade and purchased from Sigma-Aldrich (Saint-Louis, MO, United States) and otherwise if not specified. Water used to prepare buffers and sample solutions was obtained using an ELGA purelab UHQ PS water purification system (Bucks, UK). Trastuzumab (Herceptin®) sample is the EMA-approved product and formulation purchased from Roche Diagnostics GmbH (Penzberg, Germany). UPS1 was purchased from Sigma-Aldrich and RapiGest SF surfactant from Waters (Milford, MA, United States).
Peptide synthesis
Peptide HT-22 (cf. Table 1 ) and corresponding modified forms were obtained from Bachem (Bubendorf, Switzerland). These peptides correspond to tryptic fragment 22 of the heavy chain of trastuzumab (position 276-290) as well as to possible related degradation products. Purity was analytically controlled in order to be superior to 95%, and masses of each peptide were measured by matrix-assisted laser desorption/ionization time-of-flight MS. (MALDI-TOF MS) Peptide HT-3 (cf. Table 1 ) was synthesized at the Centre d'Immunologie Pierre Fabre (Saint-Julien-en-Genevois, France) using Fmoc chemistry. Purity was shown to be superior to 95%, and masses were measured by MALDI-TOF MS before use. These peptides correspond to tryptic fragment 3 of the heavy chain of humanized antibody. Sequence and theoretical masses of the peptides and their isoforms are compiled in Table 1 .
Trastuzumab sample preparation
A volume corresponding to 100 μg was used to form a marketed formulation (21 mg/ml). Samples were first diluted using milliQ water to a final concentration of 6.7 μg/μl. Samples were then diluted using 0.1% RapiGest surfactant to reach a final concentration of 3.35 μg/μl and heated to 40°C for 10 min. Dithiothreitol (DTT) was added to the sample to a final concentration of 25 mM. The samples were then heated for a 5-min incubation at 95°C. After being cooled down to room temperature (RT), iodoacetamide (2-IDA) was added to the sample to a final concentration of 10 mM, and the mixture was kept in the dark for 20 min to allow alkylation of cysteines (Cys) thiol residues. A volume of 1 μl of trypsin (0.5 μg/μl) was added to the sample, which was left at room temperature for 3 h. Finally, another 1 μl volume of trypsin was added, and digestion was performed overnight at 37°C. After digestion completion, 1% (v/v) formic acid (FA) was added to the samples, which were left at RT in order to cleave the surfactant. Samples were finally diluted to a final concentration of 2.2 μM of protein using ammonium acetate 50 mM (pH 4.0).
UPS1 sample preparation
The UPS1 sample was reconstituted first in 0.1% RapiGest by adding 30 μl of the solution and heated to 40°C during 10 min. Trypsin was reconstituted by adding a volume of 40 μl of milliQ water as advised by manufacturer. DTT was added to the sample to a final concentration of 25 mM. Sample was then incubated for 5 min at a temperature of 95°C. After being cooled down to RT, 2-IDA was added to the sample to a final concentration of 10 mM, and sample was kept in the dark for 20 min. A volume of 1 μl of trypsin was added to the mixture, which was left at RT for 3 h, and another 1 μl was added afterward; digestion was carried on overnight at 37°C. After digestion completion, 1% FA (v/v) was added to the sample and left at RT for 2 h. A volume of 12 μl was sampled and concentrated to an approximate volume of 1 μl using vacuum concentration (miVAC, NY, United States).
Capillary zone electrophoresis
Capillary zone electrophoresis separations were performed using CESI8000 system from Sciex separations (Brea, CA, United States) equipped with a temperature-controlled autosampler and a power supply able to deliver up to 30 kV. Hyphenation to the mass spectrometer was carried out using the sheathless CE-ESI-MS interfacing equipped on the CESI8000 system. Bare fused-silica capillaries (total length 92 cm; 30 μm i.d.) with a characteristic porous tip on its final 5 cm were made available by Sciex separations. New capillaries were flushed at 75 psi (5.17 bar) for 10 min with methanol, 10 min with 0.1 M sodium hydroxide and then 10 min with 0.1 M hydrochloric acid and water for 20 min. Finally, the capillary was flushed 10 min at 75 psi with 10% acetic acid (AA), which was the BGE used for the separation. Unless stated, hydrodynamic injections (410 mbar for 100 s) corresponding to a total volume of 110 nl were used. Separations were performed by applying a voltage of +20 kV.
Sheathless CE-ESI-MS hyphenation
The CESI8000 system was hyphenated to a 5600+ mass spectrometer (AB Sciex, Darmstadt, Germany). The 5600+ MS is equipped with a hybrid analyzer composed of a succession of quadrupoles followed by a TOF mass analyzer. ESI source parameters were set as follows: ESI voltage À1.75 kV, gas supplies (GS1 and GS2) were deactivated, source heating temperature 150°C and curtain gas value 2 psi.
Mass spectrometry
For synthetic peptides analysis, MS/MS experiments were performed in Top10 information-dependent acquisition (IDA), accumulation time set to 250 ms for MS scans and 80 ms for MS/MS scan leading to a duty cycle of 1.05 s. Mass/charge ratio (m/z) range was set to 100-2000 in both MS and MS/MS experiments. For trastuzumab and UPS1 characterization, experiments were carried out in Top20 IDA experiment with similar parameters (duty cycle 1.85 s).
MS/MS data analysis
For protein identification, MS/MS raw data were processed using ProteinPilot software (AB Sciex, Darmstadt, Germany). Database search was carried out using software native algorithm Paragon configured with the following parameters (1) database: Swissprot database, (2) enzyme: Trypsin/P, (3) maximum missed cleavages: 3, and (4) variable modifications (amino acid): acetylation (protein N-term), deamidation (Asn), oxidation (Met), carbamidomethylation (Cys), (e) false discovery rate <1%. If required, additional data treatment of CESI-MS/MS experiments was performed manually using PeakView software.
Results and discussions
Modified peptides separation under CZE
In order to investigate the selectivity provided under the electrokinetically driven separation, two different set of peptides incorporating the PTMs of interests were synthesized. Characteristics of those peptides are summarized in Table 1 . Each peptide set consists of the considered peptide without modification and the similar peptide bearing Asn deamidation, Asp isomerization or both modifications. Note as these peptides are based on actual tryptic peptides, C-terminal extremity is composed of either a lysine (Lys) or an arginine (Arg) in order to emphasize the characterization of tryptic peptides (Table 1) , while peptide synthesis allows to obtain independently the same peptide with different Asp conformation. The first set of peptides (HT-22) contains two distinctive modification sites: an Asp residue in position 6 (D 6 ) and an Asn residue in position 12 (N 12 ), which can undergo through isomerization and deamidation/isomerization, respectively. Different mixtures of the considered peptides were prepared in order to determine whether CZE enables separation regarding strictly Asn deamidation and Asp isomerization. As emphasized in Fig. 2 , the separation of a mixture constituted of HT-22 and HT-22 (deaN 12 ) peptides exhibited two consecutive peaks. Peptide HT-22 exhibits an apparent mobility of 1.91 · 10 À5 cm 2 V À1 s À1 , while the same peptide with an Asn deamidation exhibited an apparent mobility of 1.93 · 10 À5 cm 2 V À1 s À1 , leading to a difference of 0.20 ± 0.015 min in migration times corresponding to a resolution of 1.31 (Fig. 2) . To confirm the separation regarding Asn deamidation, an equivalent mixture was prepared using HT-22 (isoD 6 ) and HT-22 (isoD 6 /deaN 12 ). Similarly, results obtained showed two consecutive peaks with a difference in migration time of 0.20 ± 0.01 min. Considering their peak width, CZE separation gives a resolution of 1.38, meaning that CZE enables a significant separation of similar peptides, which sole difference is an Asn residue experiencing deamidation. Because deamidation leads to a mass shift of 0.984 Da, which can be resolved by highresolution MS, both peaks could be unambiguously attributed, and collision-induced dissociation (CID) MS/MS spectra even allowed to determine the exact amino acid modified (Fig. 2(b) and (c)). Deamidation does not involve a change of the peptide charge in solution at the BGE pH (2.2). However, difference in migration times is explained by a modification of the hydrodynamic ) with MS isotopic profiles corresponding to each peak. (b) MS/MS spectrum corresponding to peptide HT-22. (C) MS/MS spectrum corresponding to peptide HT-22 (deaN radius of the peptide due to the deamidation. Relevance of the separation of the two peptides is supported by several observations: both peptides are detected with a charge state of (+2), which means that in case of co-migration, the modification would not be characterized because of the overlapping of their respective isotopic profiles. Additionally, samples are commonly showing partial modification, which can be extremely weak (<5%). The ability to separate the modified peptide from the intact one before ESI is therefore interesting because it prevents competition during the ionization process and increases the sensitivity of the signal.
Capillary zone electrophoresis-ESI-MS experiments were also performed to study the selectivity of the separation regarding Asp isomerization. Separation of a mixture containing peptide HT-22 (deaN 12 ) and HT-22 (isoD 6 /deaN 12 ), as emphasized in Fig. 3 , showed two consecutive peaks having a migration time difference of 0.40 ± 0.10 min and a resolution of 2.24. The capacity to separate two peptides composed of the same amino acid sequence but with two different conformation of Asp is certainly a huge advantage in that case. MS instrumental settings used in this study do not permit the characterization of Asp isomerization occurring on a peptide from MS or MS/MS data. Indeed, isomerization does not involve a difference in the mass of the tryptic peptide, meaning that it cannot be directly distinguished from TOF-MS data. Additionally, y/b fragment ions produced in CID are common to both peptides ( Fig. 3(b) and (c)). As peptide mass and charge in solution are not impacted by Asp isomerization, separation between HT-22 (deaN 12 ) and HT-22 (isoD 6 /deaN 12 ) is attributed to a change in the hydrodynamic radius of the peptide due to the different conformation. Complete separation before ionization enables to unambiguously distinguish peptides isoforms and prevents competition effect during ESI process. Baseline separation obtained suggests CZE-ESI-MS is particularly appropriate to perform a relative quantification regarding modification levels of the sample. A mixture of peptides HT-22 and HT-22 (isoD 6 ) was also analyzed using the same conditions. Results obtained revealed similarly two consecutive peaks with a migration time difference of 0.45 ± 0.04 min. Results recorded for both previous separation enable to conclude that CZE selectivity is conditioned by the presence of two different Asp isomers despite the presence of another PTM on the considered peptide.
In order to confirm and further study the selectivity of the separation, similar experiments were performed using a peptide mixture composed of peptide HT-3 (Table 1 ). Peptide HT-3 is constituted of a higher number of amino acids compared with the previously studied peptide. As emphasized in Table 1 , peptide HT-3 contains an Asp residue that can experience isomerization. The analysis of a mixture containing the two isoforms of peptide HT-3 showed again two consecutive peaks having a difference in migration times of 0.16 ± 0.01 min, those separation characteristics providing a resolution superior to 1.34. In order to confirm the nature of each peak present on the electropherogram, several mixtures of HT-3 peptides isoforms in different ratios were prepared and analyzed. Results demonstrated that the unmodified peptide is detected first, followed by the modified isoform similarly to peptide HT-22. The electrophoretic separation enables to distinguish the two peptides, while their only difference comes from the conformation of a single Asp residue showing that CZE selectivity regarding Asp conformation is not affected by the peptide composition. As mentioned before, peptide HT-22 can be affected simultaneously by Asn deamidation, Asp isomerization or simultaneously both. CZE-ESI-MS/MS analysis of a mixture containing every form of peptide HT-22 was performed. As presented in Fig. 4 , each form of the peptide could be separated in CZE, with a resolution ranging from 1.29 up to 1.63 therefore showing four independent peaks.
This result is particularly interesting as it was possible to distinguish the four different forms of HT-22 in the same experiment.
Separation regarding those minor structural changes of the peptide is explained by the conjugation of two different characteristics provided by CZE separation: the selectivity of the electrokinetically driven separation allows to distinguish analytes regarding their size and likewise the tremendous efficiency of CZE separation. Indeed, during the different experiments described previously concerning CZE selectivity study, recorded results exhibited theoretical plates counts ranging from 218 105 up to 890 837 plates.
Selectivity in tryptic digest characterization
In order to further study CZE selectivity regarding Asn deamidation and Asp isomerization, a tryptic digest of trastuzumab was characterized using similar CZE-ESI-MS conditions. Especially, we demonstrated the ability to systematically characterize, from a single analysis, the complete amino acid sequence of the protein. Alongside glycosylations could be precisely localized, and more than 10 glycans structures could be simultaneously identified using MS/MS spectra. [10] The amino acid sequence of peptide HT-22 is actually part of trastuzumab sequence. Isomerization of HT-22 (isoD 6 ) is described as influencing significantly the immunogenic activity of trastuzumab by modifying higher-order structure of the protein and for this reason is considered as a critical quality attribute. [19] As it can be observed in Fig. 5 , the extracted ion electropherograms corresponding to the different forms of peptide HT-22 showed three consecutive peaks similar to the previous experiments involving synthetic peptides. The first peak was identified as the intact peptide HT-22, while the second peak exhibiting a mass shift of 0.984 Da was identified as peptide HT-22 (isoD 6 /deaN 12 ), as confirmed by fragmentation spectra. The third peak was identified as peptide HT-22 (isoD 6 ). Additionally, migration order is consistent with experiments performed employing synthetic peptides. Results obtained clearly indicate that the selectivity contributing to the separation of peptides with Asn deamidation and/or Asp isomerization is maintained during the analysis of tryptic digests. Respective maximum intensities were used to estimate the relative abundance of each isoform. Results show that a large majority of peptide HT-22 is not modified. MS signal allowed to estimate that 94.7% of HT-22 is not experiencing any modification, while 3.3% is experiencing Asp isomerization (deaN 6 /D 12 ) and 2.0% of both Asp isomerization and Asn deamidation (N 6 /isoD 12 ) ( Fig. 5 ). Considering the quantity of digested peptides injected and their abundance in MS, HT-22 modified peptides are representing a total amount of 10.6 fmol, which reveals the outstanding ionization efficiency provided by the sheathless CZE-ESI-MS interfacing. The excellent ionization efficiency is attributed by the conjugation of several characteristics. The flow rate generated by the electroosmotic flow is significantly below 50 nl/min, which is favorable with the formation of a nanoESI. [20] The interesting point emerging from CZE-ESI-MS/MS data is that peptide HT-22 isoform exhibiting deamidation is only HT-22 (D 6 /deaN 12 ). In this case, data obtained allowed to specifically characterize the isoform, which is concerned by the modification giving new insights about the conditions of occurrence of this modification.
Several Asp residues, potentially experiencing isomerization present on the considered mAb, were also studied. CZE-ESI-MS/ MS data allowed to confirm the separation of the modified peptide from the unmodified counterpart while showing that isomerization levels for trastuzumab are quite limited, systematically inferior to 5%. Trastuzumab contains in total four Asn and six Asp residues, which modifications are influencing significantly the potency of this therapeutic protein in case of deamidation and/or isomerization. CZE-ESI-MS/MS data demonstrated for each hotspot separation of the intact peptide from modified equivalents allowing to characterize and perform the relative quantification regarding modification levels in a single experiment. Results obtained therefore demonstrate conservation of the selectivity provided by the electrophoretic separation in the case of tryptic digest characterization. Ionization efficiency provided by the instrumental settings and the ability to separate prior to the ionization process peptides having minor modifications, minimizing therefore ion suppression, demonstrated the possibility using sheathless CZE-ESI-MS coupling to detect and characterize those PTMs even in the case of weakly abundant modification levels.
Selectivity in complex sample characterization
In the last two decades, performance of MS has been tremendously improved in terms of mass accuracy, resolution as well as sensitivity, acquisition rate and dynamic range. Those improvements allow the analysis of more complex samples and the development of shotgun proteomic experiments. [21] A shotgun proteomic experiment was designed using CZE-ESI-MS/MS for the separation of a moderate complex peptide digest. The sample considered in this experiment was UPS1 standard, which is a standard protein mixture designed by the Association of Biomolecular Resources Facilities standard proteomic research group, composed of 48 human proteins ranging from 6 to 83 kDa, in equivalent quantities. [22] UPS1 is commonly used to evaluate the performances of analytical platforms, especially regarding sensitivity as well as the capacity to identify successfully proteins having significant similarities regarding their amino acid sequences. [23, 24] Samples were prepared in order to be compatible with CZE-ESI-MS analysis conditions (cf. Materials and methods). During sample preparation, samples were spiked with each form of peptide HT-22. Injection conditions were adjusted in order to perform CZE-ESI-MS/MS experiments using a quantity of 50 fmol for each protein representing a total quantity of 129 ng of digested peptides. Despite the complexity of this peptide mixture, the EIE corresponding to the m/z of peptide HT-22 and modified homologous showed that the selectivity of the separation is preserved and likewise the efficiency of the separation (Fig. 6) . Indeed, resolutions observed during experiments regarding HT-22 isoforms separation were ranging from 1.24 up to 1.92. Likewise, in mAbs tryptic digest characterization, the capacity to separate the different forms of peptide HT-22 before their transfer to the ionization source can prevent competition effect, therefore maintaining an optimal sensitivity and preventing the introduction of biases during relative quantification. CZE-ESI-MS/MS data were additionally used to identify proteins composing the mixture and assess the performances of the sheathless CZE-ESI-MS coupling. Results demonstrated that a single analysis of UPS1 sample led to the identification of all 48 proteins composing the sample through database search algorithm. Strictly relying on database search algorithm, maximum sequence coverage was 73% for lactotransferin (M th = 78289 Da), while mean sequence coverage was 35%. Results obtained show the exceptional adequacy of CZE separation in concomitance with high-resolution MS for the characterization of complex samples in shotgun bottom-up proteomic experiments as it was also showed by different groups. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] This characteristic explains the excellent results regarding sequence coverage obtained, which allowed to distinguish and identify independently proteins having significant parts of their amino acid sequences in common. Such properties of the sheathless CZE-ESI-MS/MS analysis, in particular the selectivity provided by CZE separation, enable the characterization of lowly abundant PTMs even for a complex sample of digested proteins, giving the opportunity in some cases to dispense with time and sample consuming enrichment steps during sample preparation. [26] In this work, CZE selectivity allowed to distinguish especially several peptides having different isomers of aspartic acid, enriching the level of the characterization that could be achieved in a conventional shotgun bottom-up proteomic experiment considering the type of mass analyzer used during the experiments.
Conclusions
In this work, we describe the use of sheathless CZE-ESI-MS/MS to enable highly sensitive and independent characterization of Asn deamidation and Asp isomerization of peptides in bottom-up proteomic experiments. CZE separation selectivity regarding the considered modifications was extensively investigated using several sets of synthetic model peptides. Results demonstrated that CZE conditions employed allowed to separate an intact peptide from the different homologous experiencing Asn deamidation, Asp isomerization or both modifications independently with a resolution systematically higher than 1.29. Selectivity is attributed to the electrokinetically driven separation mechanism of CZE, which enables separation of analytes exhibiting different hydrodynamic radii. Separation of peptide isoforms experiencing Asn deamidation and Asp isomerization provides an optimal sensitivity considering ESI ionization process by limiting competition during ionization and additionally preventing the introduction of biases that may hamper estimation of sample modification levels. These characteristics were emphasized in the experiments by the ability to detect weak modification levels inferior to 5% and the possibility to estimate independently modification levels for several PTMs occurring on the same peptide. Results proved the conservation of CZE selectivity even in the case of characterization of complex samples. Additionally, sheathless CZE-ESI-MS/MS data allowed to successfully identify all proteins composing the UPS1 sample in a single analysis using a total injection of 129 ng of digested proteins with excellent sequence coverage up to 73% allowing to identify proteins respectively having extended amino acid sequence homology.
Results obtained demonstrate the adequacy of CZE-ESI-MS/MS conditions with bottom-up proteomics experiments while providing an outstanding sensitivity for detection and identification of faintly abundant PTMs by favoring ionization efficiency. Electrophoretic separation of modified peptides from their intact counter parts, even for modifications inducing only a conformation of a single amino acid, appears as a valuable asset for biological samples characterization.
